Health Care & Life Sciences
Disappointing quarter puts WellPoint brass on hot seat
February 11, 2012
Greg AndrewsAnalysts say the company has struggled to generate the consistent earnings that rivals have, in part because of mispricing
of its Medicare Advantage senior coverage.
MoreBioCrossroads has stoked state's life sciences industry, but challenges remain
February 11, 2012
J.K. WallIn the 10 years BioCrossroads has been promoting life sciences in Indiana, the effort has netted more than 330 new companies,
an infusion of more than $330 million in venture capital, a tripling of exports, and a growing number of mentions in national
reports on life sciences.
MoreBreast cancer charity tries to avoid collateral damage from Komen controversy
February 11, 2012
IBJ StaffThe Pink Ribbon Connection distinguishes its mission from one of the country's most powerful health advocacy groups.
MoreLawsuit filed over denial of senior's home care
February 8, 2012
IBJ Staff and Associated PressA Carmel-based health insurer once owned by Conseco Inc. is being sued for refusing to pay claims for in-home care submitted
by California senior citizens.
MoreHealth care VC hits new Indiana low in 2011
February 6, 2012
J.K. WallIndiana companies landed just $14.1 million in venture funding last year, the lowest amount of capital flowing to the
state’s health care sector since BioEnterprises began tracking such deals in 2005.
MoreRoche sales rise 4 percent in 2011
February 6, 2012
J.K. WallRoche Diagnostics Corp.’s North American business, which is headquartered in Indianapolis, posted a 4-percent boost
in sales last year on the strength of its fluid analyzer business unit, even though its diabetes sales fell.
MoreDrugmakers singing same song: 2012 will be tough
February 2, 2012
Associated PressFor drugmakers, the golden era of the 1990s and early part of the last decade, when they seemed to effortlessly churn out
new multibillion-dollar pills for the masses along with double-digit quarterly profit increases, is not even in the rearview
mirror any more.
MoreBaldwin & Lyons ends tough year with quarterly profit
February 2, 2012
Indianapolis-based Baldwin & Lyons Inc. turned a profit in the fourth quarter, but it wasn’t enough to erase a dismal
2011 plagued by catastrophic losses.
MoreLilly eying deal with Turkish drug company
January 31, 2012
Bloomberg NewsEli Lilly and Co. is among about a half-dozen companies interested in buying a stake in Mustafa Nevzat Ilac Sanayii AS in
a deal that may value the Turkish drugmaker at $1 billion, sources say.
MoreCommunity agrees to absorb Howard Regional
January 31, 2012
J.K. WallKokomo’s Howard Regional Health System has signed a letter of intent to join the Community Health Network less than
four months after it broke off a merger deal with Indiana University Health.
MoreLilly's quarterly profit tumbles, but tops Wall Street estimates
January 31, 2012
J.K. WallPatent expirations on Gemzar and Zyprexa contributed to the 27-percent earnings decline, but CEO John Lechleiter touted better-than-expected
sales of other products.
MoreSymmetry Ex-CEO Moore to return $450,000 in clawback suit
January 30, 2012
Bloomberg NewsSymmetry Medical Inc.’s former CEO will return $450,000 in pay and stock proceeds to resolve U.S. Securities and Exchange
Commission claims that he profited from accounting fraud by a United Kingdom unit.
MoreGallagher sees more broker mergers coming
January 30, 2012
J.K. WallThe Carmel office of Arthur J. Gallagher & Co. just made its sixth acquisition in five years, and it expects looming changes
to tax and health laws to produce even more chances to snap up benefits brokers this year.
MorePurdue hopes center simplifies commercialization
January 30, 2012
J.K. WallPurdue University's new Innovation and Commercialization Center is supposed to be a one-stop shop for professors to get help
developing their research into products and for outside investors to find out what research is taking place there.
MoreLilly's ex-partner wins FDA approval for diabetes drug
January 29, 2012
Bloomberg NewsAmylin Pharmaceuticals Inc. and Alkermes Plc have gained U.S. clearance for Bydureon, a once-weekly diabetes shot. Eli Lilly
and Co. co-developed the drug, but ended its partnership with Amylin last year.
MoreUPDATE: WellPoint to boost primary-care pay
January 27, 2012
Associated PressHealth insurer WellPoint Inc. plans to improve primary care reimbursement and start paying for care management it doesn't
currently cover, changes that could give patients more quality time with their doctors.
MoreIndiana House backs broader ban on synthetic drugs
January 26, 2012
Associated PressThe Indiana House has approved a bill that would broaden the state's ban on synthetic drugs to include compounds nicknamed
"bath salts" and others that mimic marijuana.
MoreIndiana Senate panel backs limits on abortion pill
January 25, 2012
Associated PressThe Senate health committee voted 5-4 in support of the bill that requires that a doctor examine a woman in person before
giving her RU-486, provide written information about the physical risks of abortion and to schedule a follow-up ultrasound.
MoreWellPoint shares sink after disappointing earnings report
January 25, 2012
IBJ Staff and Associated PressWellPoint Inc.'s stock price dropped almost 5 percent Wednesday after the insurer's fourth-quarter earnings failed
to meet analyst expectations.
MoreWellPoint earnings fall well short of analysts' expectations
January 25, 2012
J.K. WallThe Indianapolis-based health insurer reported earnings of $335.3 million, or 96 cents per share, down 39 percent from the
same quarter a year ago.
MoreEli Lilly unit plans to buy feed-enzyme maker
January 24, 2012
Associated PressDrugmaker Eli Lilly and Co.'s Elanco animal health division plans to buy a privately held maker of feed-enzyme products
that improve poultry, egg and meat production.
MoreWalgreen marks retailers' push into health care
January 23, 2012
J.K. WallHealth care reform is projected to cover 30 million more people with health insurance—and overwhelm the nation’s
doctors. That's why retailers like Walgreen and Wal-Mart are moving into the space in a big way.
MorePoll: Anthem so-so in customer satisfaction
January 23, 2012
J.K. WallAnthem Blue Cross and Blue Shield ranked No. 12 in a new national customer satisfaction survey, but the poor showing doesn’t
appear to threaten the Indianapolis-based company’s business success.<
MoreDeal with Walgreen perplexes Arcadia's investors
January 21, 2012
J.K. WallSomething doesn’t add up about Arcadia Resources Inc.’s agreement to sell its pharmacy business for a low price
of $2 million, according to many of the Indianapolis company’s investors.
MoreIndiana deals ranged upward of $800 million
January 21, 2012
Mergers and acquisitions in 2011 ranged from WellPoint's acquisition of CareMore to a trucking company merger.
More
Sponsored by
ADVERTISEMENT
on Facebook & Twitter
on Facebook & Twitter
 Follow IBJ's Tweets on these topics: |
||
| @IBJNews | @Propertylines | @IBJTheScore |
| @IBJArts | @IBJHealthcare | @IBJDining |
| @IBJLists | @IBJSmallbiz | |
IBJ Featured Advertisers
ADVERTISEMENT
Back to TopCopyright © All Rights Reserved. Privacy Policy | Terms of Use.
Design, CMS, Hosting & Web Development :: ePublishing.
Additional Hosting & Delivery by
Members must realize if you stop paying your dues you will lose. Why else would your employer honor the rtw bill. Before you take this step think about what you may be giving up in the long run. Very little of your dues money goes to any dem candidate. YOu will never know how much your republican employer gives his party with money he could be paying the employee. Who will step up and demand better wages or benefits if you have no representation. Union is the way for a better life. Our carpenter union offers a 4 year apprenticeship and 2 year degree from Ivy Tech all paid for with union dues . This is a great opportunity for kids who cant afford schooling after high school. The same opportunity is there for any person,any age, either sex to provide a better living for their family. Pension, anuity, health insurance all for your dues. How is this a bad choice.
The FDIC is funded by assessments paid by banks, not taxpayers. That is not to say that bank customers don't ultimately pay the cost because, in the end, banks don't survive if they don't make profits.
SCB Bank's failure is expected to cost the government $33.9 million,dont you mean middle class another bailout our government has no money
Diogenes, the company did not call "pro-life" statements inflammatory. The IBJ article used the words "pro life."
All, the company did, is what it should do which is apologize profusely for offending people with a program that offered statements that support an infamous apartheid proponent, Dr. Verwoerd, suggest that sometimes rape is justified, and quote Biblical text to people, not looking for it.
If this is what you think is "insanity" then more companies need to behave insanely.
I totally disagree with $45mil being given to the state Attorney General's office. That money is a waste. All of the money should go to help the homeowners & the people who were foreclosed on. Why such a big percentage to state govt? They'll get to start another agency staffed with people who have new-found power & don't care about the people they serve. As soon as the program was announced, I knew the states would end up with a huge chunk of the money for themselves that would just be squandered. Or maybe Mitch Daniels will just happen to "find" another big chunk of money that was "posted in the wrong section of the state's books."